Antibodies are an unmatched tool used in biomedical research since they attach with high similarity and specificity to an array of molecules - the majority notably peptides and proteins. They are used in proceedings where categorization, quantification, localization or confirmation of a protein is essential. For in-vivo therapeutic applications
antibodies are used, due to their capability to bind firmly to a desired molecule. IDEC Pharmaceutical's Rituxan® for use against certain B-cell non-Hodgkin's lymphomas and Genentech's Herceptin® drug for precise types of breast cancer are few of the successful applications.
What are immunogens and antigens?
The terms immunogen and antigen are frequently used interchangeably, and for almost all reasons the distinction is irrelevant. In real meaning, they describe two forms of interactions between the immune system and a molecule. An antigen refers to a molecule that is able to bind to the product of that immune response, whereas an immunogen refers to a molecule that extracts an immune response in an organism's immune system. So, an immunogen is always an antigen, but an antigen may not essentially be an immunogen.
Epitopes
An epitope is the precise series of amino acids on an antigen to which the antibody binds. There are probable to be numerous epitopes against which antibodies will be created for a given antigen. Epitopes that are effortlessly available for antibody binding are preferable for antibody production. In common, the majority ultimate antigenic epitopes are hydrophilic, supple and surface orientated. This is suggested since in most natural environments, hydrophobic regions tend to reside in the interior of the protein, whereas hydrophilic regions tend to be located on the surface of proteins. In the same way, antibodies can only join to epitopes found on the surface of proteins and have a tendency to join with better affinity when those epitopes are sufficiently supple to move into available positions.
Antibodies and the immune response
Antibodies and the immune response are useful, in the context of antibody production, to comprehend the function of antibodies and some of the mechanisms contiguous their use. B-lymphocytes start producing antibodies that are exclusive to the immunogen as soon as the immune system of an organism recognizes a molecule as foreign. More significant, for each individual epitope on the antigen's surface, a detach B lymphocyte produces an antibody; thus there will be quite a few unlike antibodies that join with high similarity to any given
immunogen.
In a few cases, for instance with viruses, the fastening action of the antibody is adequate to immobilize the pathogen. In other cases, such as with bacteria, the antibodies join to surface proteins on the bacterium's surface, thus indicating to other components of the immune system that the pathogen should be damaged.
Subsequent to the pathogen has been disabled, the B cells that produced the antibodies stay in the blood stream, substitute as a type of memory security against further incursions from the similar immunogen. It is essential to remember that each B cell produces precisely one extremely precise antibody, and that any given antigen is probable to have quite a few antibodies that join to the a range of epitopes on its surface for
antibody-production purposes.
Author bio : With 35 years of experience in generating
polyclonal antibodies, Pacific Immunology Corp. is a leading global provider of
custom antibody production services. Through continual refinement of techniques, protocols and reagents, Pacific Immunology has developed the capacity to consistently generate high affinity Peptide and
Monospecific antibodies at reasonable prices.
